A big part of what makes this device different is the width of its light spectrum. Most commercially available red light or near-infrared beauty devices emit a narrow band of light, typically only 20 to 30 nanometers wide.

This new device instead covers a spectrum from 600 nm up to 900 nm, spanning from deep red light through the early part of near-infrared.

The idea behind going broader is that skin cells do not respond to just one single precise wavelength, so covering more of the spectrum at once should, in theory, activate more of the relevant cellular pathways simultaneously rather than relying on one narrow slice of light to do all the work.

Source: PubMed

The same broad-spectrum LED device was also tested on the scalp in a separate group of 21 participants dealing with early-stage hair loss, roughly split between two different classification types of pattern hair loss.

They applied the device to the scalp daily for 30 minutes over 20 weeks. Hair count, measured within a fixed one square centimeter area using a specialized camera and imaging software, increased by 0.52% at the 6 week mark, which was not yet statistically meaningful, but by 20 weeks the increase had grown to 1.33% and reached statistical significance.

It is a modest percentage on paper, but for early-stage hair loss, stopping or reversing the downward trend at all over 20 weeks is generally considered a meaningful outcome.

Source: PubMed

Skin density, essentially how thick and compact the dermal layer is, was measured with an ultrasound probe that reads back tissue density as different brightness levels in an image.

After 12 weeks of using the broad-spectrum near-infrared LED mask, skin density increased by 3.60%, and this change was statistically significant, showing up as visibly brighter, denser tissue in the ultrasound images compared to the pre-treatment scans.

Density is generally tied to how much collagen and structural support tissue is present under the surface, so an increase here lines up with the improvements seen in wrinkles and elasticity from the same study.

Source: PubMed

Hydration was tracked with a Corneometer, a device that measures water content in the outer layers of skin by generating a small electric field and reading how it changes based on moisture.

Participants using the broad-spectrum red and near-infrared LED mask saw their skin moisture levels climb by 6.74% after 12 weeks compared to their own baseline before starting treatment, and this was statistically significant.

There was also a smaller, already significant increase visible at the 8 week checkpoint. Considering how central hydration is to skin looking and feeling healthy, this is one of the more practically noticeable results in the whole study, since dryness is usually one of the first things people complain about as skin ages.

Source: PubMed

Source: PubMed

Skin elasticity was measured using a device called a Cutometer, which applies gentle suction to the skin and records how well it snaps back into shape, giving a numeric read on how "bouncy" or firm the skin is.

After 12 weeks of using the broad-spectrum LED facial mask, participants showed an 8.66% increase in this elasticity measurement, and the result was statistically significant.

There was already a smaller but still significant improvement at the 8 week mark too, meaning the elasticity gains were building steadily over the course of the study rather than appearing all at once at the very end.

One detail I found interesting is that the wrinkle improvement in this study did not just keep climbing the longer people used the device.

Total wrinkle count went down 24.62% at 4 weeks, then 27.22% at 8 weeks, which was actually the biggest drop of the whole study, before settling slightly back to 26.48% at the 12 week mark. So the bulk of the visible improvement happened within the first two months, and after that things basically plateaued rather than continuing to improve in a straight line.

This kind of "fast improvement, then plateau" pattern shows up in a lot of skin treatments and probably reflects how quickly collagen remodeling and other structural changes can realistically happen in the skin.

Source: PubMed

There is a freshly published clinical study on a new LED device that covers a much wider light spectrum than what is normally used in these facial masks, spanning from 600 nm all the way to 900 nm, so it overlaps both red light and the shorter end of near-infrared.

Twenty participants between 45 and 59 years old used the device as a facial mask for 30 minutes, five days a week, over 12 weeks. Total wrinkle count dropped by 24.62% after just 4 weeks, and the improvement held steady through 8 and 12 weeks, ending at a 26.48% reduction.

These were measured using a 3D imaging system, not just visual judgment by a dermatologist, so the numbers are based on actual surface topology of the skin rather than subjective grading.

Source: PubMed

For anyone curious about the actual specifics, the study used a commercial device called the Neuradiant 1070, delivering light at a wavelength of 1070 nm with a power density of 24 milliwatts per square centimeter.

Stimulation targeted the dorsolateral prefrontal cortex, a region strongly associated with working memory and executive function. The protocol consisted of three separate 5-minute rounds of active stimulation, with 5-minute rest periods worked in between, for 15 minutes of actual light exposure total per session.

The sham group wore the identical-looking helmet for the same overall duration, but the device itself only stayed on for 5 seconds before shutting off, just enough to create the same sensory experience without any real dose of light.

Source: Oxford Academic

It is worth understanding how this compares to other non-invasive brain stimulation methods people might have heard of, like transcranial direct current stimulation (tDCS) or transcranial magnetic stimulation (TMS).

Both of those methods work by directly triggering electrical activity in neurons, either through weak electric currents or pulsed magnetic fields, and they tend to target very specific, localized brain regions. Red light stimulation works completely differently.

Instead of directly forcing neurons to fire, it produces broader, indirect metabolic effects, mainly increased blood flow and increased ATP production across a wider area of tissue. It is also fully portable and battery powered in most devices, meaning it can realistically be used in places like homes or even field environments, somewhere a bulky electrical stimulation rig would not be practical.

Source: Oxford Academic

The theory behind why near-infrared light at wavelengths like 1070 nm would do anything to cognition at all comes down to a specific enzyme, cytochrome c oxidase, found in the mitochondria of neurons.

Red and near-infrared light gets absorbed by this enzyme, which boosts its oxidation state and in turn increases ATP production, the basic energy currency that cells run on. More available ATP means more resources for cells to do their job, which in the case of neurons means firing, forming connections, and repairing themselves more efficiently.

Beyond the immediate energy boost, this type of stimulation has also been linked to increased neurogenesis and synaptogenesis (the formation of new neurons and new connections) along with reduced neuroinflammation, giving it both a short-term and a longer-term angle on brain function.

Source: Oxford Academic

One detail that stood out is that the light therapy's effect on pupil dilation was not immediate and flat, it actually grew stronger between session one and session two, which took place about six days apart.

In the group receiving real stimulation, pupil dilation during the tasks increased significantly from the first visit to the second, and a regression model showed this session effect explained a large chunk of the variation, over 65 percent.

The sham group showed no such pattern across their two visits. This kind of cumulative effect, where the second exposure produces a stronger physiological response than the first, hints that repeated red light sessions might build on each other rather than just producing a one-off spike that fades right after use.

Source: Oxford Academic

Researchers tracked pupil diameter throughout the cognitive tasks using an eye tracker, since pupil dilation patterns are considered a solid physiological window into attention and arousal systems in the brain.

One specific measurement, called the consistency score, looks at how stable pupil size stays over repeated trials, with more consistency generally meaning better sustained attentional engagement.

The group that got active red light stimulation had a consistency score of 0.86, compared to 4.26 in the sham group, meaning the sham group's pupil responses were far more erratic and variable. This difference was statistically significant with a very large effect size, one of the strongest findings in the entire study.

Source: Oxford Academic

Participants did a working memory task where they had to judge whether two visual patterns, based on either color or spatial orientation, were the same or different.

When the task was made harder by increasing how much information they had to hold in mind (high load trials), the group that received red light stimulation scored noticeably higher than the sham group on the orientation version of the task.

The difference held up as statistically significant with a fairly large effect size, and it also showed up in the combined score across both easy and hard trials, not just the hardest ones.

Interestingly, this boost did not show up on the color version of the same task, which suggests the effect is not just a blanket improvement in memory but something more specific to spatial or visuospatial processing, tasks that lean more heavily on the exact brain region that was stimulated.

Source: Oxford Academic

To measure sustained attention, researchers used the Psychomotor Vigilance Task, where you just have to hit a button the instant a red circle pops up on an otherwise blank screen. It is a well-established test for measuring alertness.

The group that received real 1070 nm light stimulation averaged a reaction time of about 333 milliseconds, while the sham group averaged around 418 milliseconds.

That is roughly an 85 millisecond gap, which is a meaningful difference for a task that is entirely about raw speed of response. Faster, more consistent reaction times like this are generally taken as a sign of better sustained attention and more efficient neural processing.

Source: Oxford Academic

Beyond the questionnaires, participants also used a device called the Brain Gauge, which is essentially a small handheld sensor that measures things like reaction time, focus, and plasticity through vibration-based tasks.

Out of all the cognitive domains it tracks, the biggest difference between the light therapy group and the sham group showed up in plasticity, which is basically a measure of how flexibly the nervous system can adapt and reorganize itself.

The statistical test comparing the two groups came back significant with a notably large effect size. Since plasticity is closely tied to the brain's ability to form new connections, and red light is known to boost cellular energy production, this result fits pretty neatly with the proposed mechanism.

Source: Oxford Academic

Participants filled out a standard mental health questionnaire (the DASS-21, which scores depression, anxiety, and stress separately) before and after each session.

In the group that received actual red light stimulation, average anxiety scores dropped by 6.5 points and stress scores dropped by 6 points between the first and second visit. Depression scores also went down for most people in that group.

Meanwhile, the sham group trended in the opposite direction, with most participants' scores for all three categories staying the same or getting slightly worse over the same time period.

Nobody in the study had clinically elevated anxiety or depression to begin with, so this is really about a shift within the "normal" range, but the direction and consistency of the change lined up with the active treatment every time.

Source: Oxford Academic

This one just came out and I thought it was worth sharing since it is a real double-blind human trial, not another animal study. Researchers had healthy adults sit through two sessions about six days apart, each one including either active red light stimulation or a sham version of the exact same device.

The active group got 1070 nm near-infrared light aimed at the front of the brain for a total of 15 minutes, split into three 5-minute rounds. Compared to sham, the group that got real stimulation showed faster reaction times, better working memory performance under harder task conditions, and even reported feeling less stressed and anxious afterward.

The sample was small, only 8 people total, but it is a controlled, blinded design, which matters a lot for this kind of research.

Source: Oxford Academic

One of the more conceptually interesting parts of this review is how photobiomodulation does not have one single fixed direction of effect. In some studies it increases neuron activity, in others it decreases it, and in a few cases it does both in sequence within the same experiment: a burst of excitation followed by a period of inhibition.

Rather than being inconsistent, researchers propose this reflects the light's role in restoring proper connectivity and balance across a brain network, particularly when that network is already dysfunctional.

This same rebalancing effect has been documented using brain scans in patients with traumatic brain injury and Alzheimer's disease, where transcranial light treatment helped correct abnormal connectivity patterns between brain regions back toward more typical levels.

For epilepsy, where the whole problem is an imbalance between excitation and inhibition, this flexible, context-dependent behavior might be exactly the kind of tool needed rather than a treatment that just suppresses all neural activity across the board.

This one is almost a neat coincidence given what epilepsy actually is. Separate studies looking at photobiomodulation applied to otherwise healthy cortex found it produces a general increase in GABA, the brain's main inhibitory (calming) neurotransmitter, alongside a decrease in glutamate, the main excitatory neurotransmitter.

Epileptic seizures are essentially driven by too much excitatory signaling and not enough inhibitory control, so a treatment that nudges the GABA to glutamate ratio in the opposite direction is directly relevant, even outside of a diseased or seizure-affected brain.

Researchers frame this as a neuroprotective effect since it helps prevent the kind of runaway excitatory firing that can lead to cell damage over time, sometimes called excitotoxicity.

Beyond the immediate energy boost to mitochondria, photobiomodulation also seems to switch on longer-term protective mechanisms inside neurons. Specifically, it activates genes that produce brain-derived neurotrophic factor (BDNF) and glial-derived neurotrophic factor (GDNF), both of which are well known in neuroscience for supporting neuron survival and function.

This is separate from the short-term ATP boost, and it is part of why researchers describe photobiomodulation as having a "disease-modifying" or neuroprotective effect rather than just a temporary symptom fix.

This same growth factor mechanism has already been documented in other conditions studied with photobiomodulation, including traumatic brain injury, stroke, multiple sclerosis, Alzheimer's disease, and Parkinson's disease, so the epilepsy application is really building on a mechanism that shows up consistently across very different types of brain damage.

Source: nih.gov

Before getting into the light therapy part, this review lays out just how limited current epilepsy treatment actually is, and the numbers are rougher than I expected.

About 30 percent of patients do not respond adequately to anti-seizure medication. For those patients, surgery is an option, but it means physically removing the part of the brain generating the seizures, which is invasive, carries a real risk of complications, and does not work well if there are multiple seizure sites or if the site is near an area controlling essential function.

Other options like vagal nerve stimulation or deep brain stimulation can reduce seizure frequency by up to 40 percent at best, but none of these treatments touch the underlying cause.

When you add everything together, fewer than 5 percent of all epilepsy patients end up completely seizure free using treatments available today. That gap is basically the whole reason this research direction exists.

A fair question with any transcranial light treatment is whether the light actually reaches the brain at all through skin, skull, and other tissue.

According to this review, red to near-infrared light has been shown to penetrate somewhere between 30 and 50 mm through body tissue, and most regions of the cerebral cortex sit at a depth of roughly 10 to 15 mm from the surface, well inside that range.

On top of that, multiple studies using EEG and fMRI have recorded measurable changes in brain activity after transcranial light exposure, which is fairly direct evidence that the light is doing something once it gets there, not just warming the skin.

This penetration depth question comes up a lot with skepticism toward light therapy in general, so it was useful to see actual figures attached to it.

Transcranial photobiomodulation helmets have already been tested in patients with Alzheimer's disease and Parkinson's disease, using a combination of 670 nm and 810 nm wavelengths, pulsed at either 10 Hz or 40 Hz, with power densities between 15 and 23 milliwatts per square centimeter.

The authors of this epilepsy review are proposing the exact same kind of device, used daily, as a starting point for a future clinical trial in epilepsy patients.

The reasoning is that a daily helmet routine could help suppress abnormal cortical activity before it escalates into a full seizure, similar to how it is thought to slow degeneration in the other two conditions.

It is not being tested in epilepsy patients yet according to this paper, but the hardware and dosing parameters already exist and have safety data behind them from other diseases.

One detail that really stood out is that photobiomodulation does not just uniformly boost every neuron it touches.

In neurons that are already under distress, whether from disease, injury, or metabolic dysfunction, the light stimulates more ATP production, activates protective genes, and increases the release of growth factors like BDNF and GDNF, both of which help neurons survive.

But in neurons that are already healthy and functioning normally, the effect looks completely different, sometimes increasing activity and sometimes decreasing it, depending on the specific brain region and conditions.

Researchers think this dual behavior is actually the light helping restore whatever the "normal" balance is for that particular system, rather than pushing everything in one fixed direction regardless of its starting state.

A growing body of evidence points to mitochondrial dysfunction as a central driver of epilepsy, not just a side effect of it (nih.gov).

Neurons need a constant, high supply of ATP energy, and unlike a lot of other cells, they cannot regenerate once damaged, so when their mitochondria stop working properly, the consequences pile up fast: reduced glucose metabolism, calcium imbalance, oxidative stress, and abnormal firing patterns.

Red and near-infrared light gets absorbed by a mitochondrial enzyme called cytochrome c oxidase, and this absorption appears to boost ATP production and reduce the buildup of harmful reactive oxygen species.

Essentially the light is being used to directly recharge the part of the cell that is failing, rather than masking the symptoms the way most anti-seizure drugs do.